Syngene acquires first manufacturing site in US

The acquisition will help the company to better serve its customers across both human and animal health market segments, Syngene International said in a statement.

Syngene International on Monday said it has acquired its first manufacturing facility in the US for around USD 50 million.

Syngene USA Inc, a wholly-owned subsidiary of the company, has acquired the site from Emergent Manufacturing Operations Baltimore, LLC.

The acquisition will help the company to better serve its customers across both human and animal health market segments, Syngene International said in a statement.

Overall investment in the US facility is estimated at around USD 50 million, including the cost of acquisition (USD 36.5 million) and expenses to make the facility operational, it added.

The acquisition is expected to close in March 2025, subject to the satisfaction of customary closing conditions, it said.

Syngene International shares on Monday ended 0.22 per cent down at Rs 678 apiece on BSE.